Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Share-based Compensation: 2021-2024

Historic Share-based Compensation for biote (BTMD) over the last 4 years, with FY2024 value amounting to $8.7 million.

  • biote's Share-based Compensation rose 734.97% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 276.36%. This contributed to the annual value of $8.7 million for FY2024, which is 355.53% down from last year.
  • According to the latest figures from FY2024, biote's Share-based Compensation is $8.7 million, which was down 355.53% from $9.1 million recorded in FY2023.
  • In the past 5 years, biote's Share-based Compensation registered a high of $82.2 million during FY2022, and its lowest value of $285000.0 during FY2021.
  • For the 4-year period, biote's Share-based Compensation averaged around $25.1 million, with its median value being $8.9 million (2023).
  • As far as peak fluctuations go, biote's Share-based Compensation skyrocketed by 2873508.77% in 2022, and later tumbled by 8897.91% in 2023.
  • Annual analysis of 4 years shows biote's Share-based Compensation stood at $285000.0 in 2021, then surged by 28735.09% to $82.2 million in 2022, then crashed by 88.98% to $9.1 million in 2023, then dropped by 3.56% to $8.7 million in 2024.
  • Its last three reported values are $8.7 million in FY2024, $9.1 million for FY2023, and $82.2 million during FY2022.